|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:AmeriPath
gptkb:Celera_Corporation
gptkb:ExamOne
gptkb:LabOne
|
|
gptkbp:awards
|
gptkb:Forbes_America's_Best_Employers
Fortune 500 company
|
|
gptkbp:CEO
|
gptkb:James_E._Davis
|
|
gptkbp:competitor
|
gptkb:BioReference_Laboratories
gptkb:LabCorp
gptkb:Mayo_Clinic_Laboratories
|
|
gptkbp:divested
|
gptkb:HemoCue
gptkb:MedPlus
gptkb:NID
|
|
gptkbp:founded
|
1967
|
|
gptkbp:founder
|
gptkb:Paul_A._Brown
|
|
gptkbp:headquartersLocation
|
gptkb:Secaucus,_New_Jersey,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Quest Diagnostics
|
|
gptkbp:industry
|
healthcare
medical diagnostics
|
|
gptkbp:ISIN
|
US74834L1008
|
|
gptkbp:listedOn
|
gptkb:S&P_500
|
|
gptkbp:logo
|
Quest Diagnostics logo.svg
|
|
gptkbp:marketCap
|
$15.5 billion (2023)
|
|
gptkbp:notableProduct
|
COVID-19 testing
genetic testing
blood testing
drug testing
|
|
gptkbp:numberOfEmployees
|
49000
|
|
gptkbp:numberOfLocations
|
2200 patient locations
|
|
gptkbp:officeLocation
|
gptkb:Secaucus,_New_Jersey
|
|
gptkbp:parentCompany
|
independent
|
|
gptkbp:previousName
|
gptkb:MetPath
|
|
gptkbp:publiclyTraded
|
true
|
|
gptkbp:revenue
|
$9.88 billion (2022)
|
|
gptkbp:servesArea
|
gptkb:United_States
international
|
|
gptkbp:services
|
gptkb:insurance
diagnostic testing
clinical laboratory services
|
|
gptkbp:SIC
|
8071
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:DGX
|
|
gptkbp:subsidiary
|
gptkb:AmeriPath
gptkb:Athena_Diagnostics
gptkb:ExamOne
gptkb:Med_Fusion
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.questdiagnostics.com/
|
|
gptkbp:bfsParent
|
gptkb:quest
|
|
gptkbp:bfsLayer
|
4
|